This content is from: Premium Hedge Funds Are Holding Their Breath on This Biopharma IPO Several prominent hedge funds disclosed sizable stakes in PepGen, which went public earlier this month. By Stephen Taub May 23, 2022
This content is from: Portfolio This Private Equity Fund Was the Most Popular Among Pensions Last Year New research shows the top pensions allocating capital to private markets — and their favorite funds of 2021. By Alicia McElhaney April 26, 2022
This content is from: Portfolio As the Fed Party Ends, Private Equity Prepares for the Hangover The tightening macroeconomic environment poses challenges for an asset class that thrives on borrowed money. By Jessica Hamlin May 06, 2022
This content is from: Portfolio Public Pensions Want to Divest From Russia. But Can They? “The problem is the Russian stock market hasn’t opened this week,” CalSTRS CIO Chris Ailman said. By Alicia McElhaney March 04, 2022
This content is from: Portfolio The Markets Are Reverting Back to Rational Investing The dominance of market-cap weighted indexing means that the carnage in technology isn’t done pummeling allocators. By Julie Segal May 27, 2022
This content is from: Corner Office The SEC Is Bearing Down on Private Equity. Blame Public Pensions. Regulators can no longer ignore private equity, now that public pension funds provide 35 percent of the industry’s capital, argues a new paper. By Jessica Hamlin January 25, 2022
